Undervalued and trendI think there is a cautious approach to this stock right now. With a 3yr time horizon to $100M. The stock is going to move up slowly unit the FDA news is announced. After we could see a pull back from speculator selling or a good pop to $6 or both.
I'm not saying much in terms of insight, but I like these small tech breakthrough companies like OPS because more than likely they will get bought out.